<DOC>
	<DOCNO>NCT01530373</DOCNO>
	<brief_summary>Hot flash present considerable problem many breast cancer patient ; symptom may intensify hormonal therapy , aromatase inhibitor tamoxifen . This study examine value solifenacin ( muscarinic acetylcholine receptor antagonist ) reduce hot flash , compare clonidine ( medication often use treat hot flash ) .</brief_summary>
	<brief_title>Solifenacin Compared Clonidine Reducing Hot Flashes Among Breast Cancer Patients</brief_title>
	<detailed_description>There considerable interest develop new treatment strategy manage hot flash among woman breast cancer , view limitation associate currently available treatment . This randomized study evaluate safety efficacy 3 week solifenacin compare 3 week clonidine , woman receive adjuvant hormonal therapy ( aromatase inhibitor tamoxifen ) breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Women history invasive breast cancer DCIS Currently take aromatase inhibitor tamoxifen Not receive hormone replacement therapy minimum one month Age 18 year older Selfreported hot flash great seven time per week Selfreported hot flash least one month Receiving treatment hot flash within past month , include estrogen , progestin , androgen , gabapentin , antidepressant venlafaxine , paroxetine , citalopram , sertraline , etc . Current use clonidine solifenacin . ( If patient one month , eligible ) History severe renal moderate severe hepatic impairment , indicate physical exam medical record Concurrent plan chemotherapy radiotherapy ( within next 3 month ) Currently receive monoamine oxidase inhibitor , Ldopa , piribedil , barbiturate , moxifloxacin , pimozide , antihypertensive treatment Currently use CYP3A4 inducer ( i.e. , aminoglutethimide , carbamazepine , dexamethasone , efavirenz , ethosuximide , griseofulvin , modafinil , nafcillin , nevirapine , oxcarbazepine , phenobarbital , phenylbutazone , phenytoin , primidone , rifabutin , rifampin , rifapentine , St. John 's wort , sulfadimidine , sulfinpyrazone , troglitazone ) potent CYP3A4 inhibitor ( i.e. , clarithromycin , chloramphenicol , erythromycin , imatinib mesylate , Indinavir sulfate , itraconazole , ketoconazole , nefazodone , nelfinavir mesylate , ritonavir , telithromycin , troleandomycin ) . Uncontrolled poorly control closedangle glaucoma , urinary retention , gastric retention ( evaluated history &amp; physical exam medical record ) Hypotension ( systolic BP &lt; 80 ) Severe coronary insufficiency , conduction disturbance , recent myocardial infarction ( within past 3 month ) , cerebrovascular disease , syncope ( evaluated history &amp; physical medical record ) History allergy adverse reaction clonidine solifenacin ECOG status &gt; 2 ( bed 50 % day )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hot flash</keyword>
	<keyword>breast cancer</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>solifenacin</keyword>
	<keyword>clonidine</keyword>
	<keyword>quality life</keyword>
</DOC>